Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RG.. please prove me wrong soon...

Consider these questions from a farmers perspective. If the agreement between TPL and PTSC is so lopsided in TPL's favor, then why isn't TPL flush with cash and able to pay Moore? Is TPL really benefitting significantly from the lopsided agreement? If yes in what ways? Dosn't TPL have a pretty high burn rate for all the employees they have surrounding the MMP? Isn't TPL and PTSC in the same boat, suffering from the impact of the USPTO reexamination process? Isn't the USPTO reexamination the real issue of concern at this time and not the licensing agreement between TPL and PTSC? Is the agreement with TPL really that lopsided considering TPL is doing all the work? Can we really be surprised at the behavior of the BOD at the time of the agreement considering the baggage that PTSC was carrying at the time?

Do you think PTSC is in better shape today as compared to when the agreement was made?

Which of these issues in your opinion would you consider the most important at this time to the success of PTSC and that will ultimately move the share price north significantly? Note that I have listed them in no particular order. Please rank each item on a scale of 1 to 10 10 being very important.

1) Revalidation of the 336 patent by the USPTO with teeth.

2) Sales of PDSG products.

3) The licensing agreement with TPL.

4) RG providing clearer communication.

5) TPL's credibility and trustworthiness.

6) PTSC BOD members.

7) PTSC BOD and executive compensation levels.

8) Other

Steve

Share
New Message
Please login to post a reply